We are live on ! Find out more
RJA

Raymond James & Associates Portfolio holdings

AUM $164B
1-Year Est. Return 33.91%
This Fund
S&P 500
This Quarter Est. Return
+2.81%
1 Year Est. Return
+33.91%
3 Year Est. Return
+39.99%
5 Year Est. Return
+107.66%
10 Year Est. Return
+436.07%
AUM
$39.2B
AUM Growth
+$2.5B
Cap. Flow
+$1.83B
Cap. Flow %
4.67%
Top 10 Hldgs %
16.25%
Holding
3,494
New
280
Increased
1,537
Reduced
1,324
Closed
255

Sector Composition

Rank Sector Weight
1 Technology 9.2%
2 Financials 8.97%
3 Healthcare 8.75%
4 Industrials 7.19%
5 Consumer Staples 6.63%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TECK icon
3151
CALL
Teck Resources
TECK
$32.6B
$14K ﹤0.01%
15,200
-12,200
-45% -$264K
TGT icon
3152
CALL
Target
TGT
$68B
$14K ﹤0.01%
44,700
-33,100
-43% -$2.4M
TRX icon
3153
TRX Gold Corp
TRX
$344M
$14K ﹤0.01%
28,513
RTN
3154
CALL
DELISTED
Raytheon Company
RTN
$14K ﹤0.01%
11,200
UNXL
3155
DELISTED
Uni-Pixel, Inc.
UNXL
$14K ﹤0.01%
+14,000
New +$17.5K
EXC icon
3156
CALL
Exelon
EXC
$47B
$13K ﹤0.01%
60,566
+21,450
+55% +$509K
PLUG icon
3157
Plug Power
PLUG
$3.04B
$13K ﹤0.01%
10,434
-16,925
-62% -$24.9K
XBI icon
3158
CALL
State Street SPDR S&P Biotech ETF
XBI
$10.3B
$13K ﹤0.01%
40,700
+13,200
+48% +$815K
TVIA
3159
DELISTED
TerraVia Holdings, Inc. Common Stock
TVIA
$13K ﹤0.01%
11,001
-1,600
-13% -$2.9K
CYTR
3160
DELISTED
CytRx Corp
CYTR
$13K ﹤0.01%
5,833
+2,500
+75% +$7.35K
PLM
3161
DELISTED
PolyMet Mining Corp.
PLM
$12K ﹤0.01%
1,550
+150
+11% +$1.2K
BBY icon
3162
CALL
Best Buy
BBY
$17.3B
$11K ﹤0.01%
+11,700
New +$497K
CVM icon
3163
CEL-SCI Corp
CVM
$30.1M
$11K ﹤0.01%
227
-6
-3% -$921
EPD icon
3164
CALL
Enterprise Products Partners
EPD
$81.7B
$11K ﹤0.01%
31,000
PEP icon
3165
CALL
PepsiCo
PEP
$190B
$11K ﹤0.01%
+49,800
New +$5.21M
BCOV
3166
CALL
DELISTED
Brightcove, Inc.
BCOV
$11K ﹤0.01%
20,000
-13,000
-39% -$127K
VIAB
3167
CALL
DELISTED
Viacom Inc. Class B
VIAB
$11K ﹤0.01%
54,800
+3,900
+8% +$143K
CA
3168
CALL
DELISTED
CA, Inc.
CA
$11K ﹤0.01%
+36,400
New +$1.16M
YELL
3169
CALL
DELISTED
Yellow Corporation Common Stock
YELL
$11K ﹤0.01%
+26,300
New +$331K
CSCO icon
3170
CALL
Cisco
CSCO
$479B
$10K ﹤0.01%
308,400
-330,900
-52% -$10.1M
MDLZ icon
3171
CALL
Mondelez International
MDLZ
$79.9B
$10K ﹤0.01%
18,400
-500
-3% -$21.5K
JCP
3172
CALL
DELISTED
J.C. Penney Company, Inc.
JCP
$10K ﹤0.01%
81,200
-9,300
-10% -$84K
NAVB
3173
DELISTED
Navidea Biopharmaceuticals Inc.
NAVB
$10K ﹤0.01%
800
-50
-6% -$793
DNN icon
3174
Denison Mines
DNN
$2.91B
$9K ﹤0.01%
17,958
-1,499
-8% -$695
IRDM icon
3175
CALL
Iridium Communications
IRDM
$5.29B
$9K ﹤0.01%
26,600
-20,000
-43% -$178K

Similar funds

Raymond James & Associates's Q4 2016 Portfolio in Review

As of Q4 2016, Raymond James & Associates held 3,494 positions worth $39.2B, up 6.8% from $36.7B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Raymond James & Associates deployed $1.83B of net new capital in Q4 2016, opening 280 new positions and adding to 1,537 existing holdings. Its largest new stake was Invesco S&P 500 High Beta ETF: 442,572 shares worth $16.2M.

By sector, the portfolio is most concentrated in Technology at 9.2% of assets, up from 9.1% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was Reynolds American Inc, an estimated $76.5M trimmed.

  • Raymond James & Associates's largest Q4 2016 buy was Invesco S&P 500 High Beta ETF: 442,572 shares worth $16.2M.
  • Raymond James & Associates added most to iShares Core US Aggregate Bond ETF in Q4 2016, an estimated $118M increase.
  • Raymond James & Associates's biggest Q4 2016 reduction was Reynolds American Inc, cutting an estimated $76.5M.
  • Raymond James & Associates fully exited Amsurg Corp in Q4 2016, selling an estimated $29.2M.
  • Raymond James & Associates's ten largest holdings make up 16% of its $39.2B portfolio in Q4 2016.
  • Raymond James & Associates opened 280 new positions and closed 255 in Q4 2016.
  • Raymond James & Associates's portfolio value rose 6.8% quarter-over-quarter to $39.2B.

Based on Raymond James & Associates's 13F filing for Q4 2016, filed 14 Feb 2017.